FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ulrich Spandau

Research Profile

Anatomy

Chemicals & Drugs

Physiology

Disorders

Procedures

Concepts & Ideas

Co-author Network

Publications

TOP 3
Jost B Jonas; Teodosio Libondi; Lidia Golubkina; Ulrich H M Spandau; Frank Schlichtenbrede; Florian Rensch
Combined intravitreal bevacizumab and triamcinolone in exudative age-related macular degeneration.
Urs Vossmerbaeumer; Ulrich H M Spandau; Kathrin Kleinhuber; Sabine Zeller; Anastasios Chatzikonstantinou; Stephan Ruggiero; Rainer Birck
Arrest of endogenous ocular nocardiosis under linezolid therapy.
Florian Rensch; Ulrich H M Spandau; Anne Wickenhäuser; Jost B Jonas
Diffuse diabetic macular oedema treated with intravitreal bevacizumab or triamcinolone acetonide.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ulrich Spandau (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Jost B Jonas; Teodosio Libondi; Lidia Golubkina; Ulrich H M Spandau; Frank Schlichtenbrede; Florian Rensch
Combined intravitreal bevacizumab and triamcinolone in exudative age-related macular degeneration.
Acta ophthalmologica 2010;88(6):630-4.
2010: Urs Vossmerbaeumer; Ulrich H M Spandau; Kathrin Kleinhuber; Sabine Zeller; Anastasios Chatzikonstantinou; Stephan Ruggiero; Rainer Birck
Arrest of endogenous ocular nocardiosis under linezolid therapy.
Acta ophthalmologica 2010;88(3):381-3.
2010: Florian Rensch; Ulrich H M Spandau; Anne Wickenhäuser; Jost B Jonas
Diffuse diabetic macular oedema treated with intravitreal bevacizumab or triamcinolone acetonide.
Acta ophthalmologica 2010;88(2):e36-7.
2009: Frank C Schlichtenbrede; Ulrich H M Spandau; Björn Harder; Jost B Jonas
Lens capsular bag irrigation for low-grade endophthalmitis.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie 2009;247(9):1273-6.
2009: Florian Rensch; Jost B Jonas; Ulrich H M Spandau
Early intravitreal bevacizumab for non-ischaemic central retinal vein occlusion.
Acta ophthalmologica 2009;87(1):77-81.
2009: Florian Rensch; Jost B Jonas; Ulrich H M Spandau
Early intravitreal bevacizumab for non-ischaemic branch retinal vein occlusion.
Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift für Augenheilkunde 2009;223(2):124-7.
2008: Ulrich H M Spandau; Franziska Vom Hagen; Hans-Peter Hammes; Jost B Jonas
Effect of intravitreal triamcinolone acetonide on retinal apoptosis in experimental retinal neovascularization.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie 2008;246(7):1069-70.
2008: Florian Rensch; Ulrich H M Spandau; Frank Schlichtenbrede; Stefan von Baltz; Teodosio Libondi; Jost B Jonas; Urs Vossmerbaeumer
Intravitreal bevacizumab for myopic choroidal neovascularization.
Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye 2008;39(3):182-5.
2008: Urs Vossmerbaeumer; Ulrich H M Spandau; Stefan V Baltz; Anne Wickenhaeuser; Jost B Jonas
Intravitreal bevacizumab for choroidal neovascularisation secondary to punctate inner choroidopathy.
Clinical & experimental ophthalmology 2008;36(3):292-4.
2008: Jost B Jonas; Ulrich H M Spandau; Frank Schlichtenbrede
Short-term complications of intravitreal injections of triamcinolone and bevacizumab.
Eye (London, England) 2008;22(4):590-1.
2007: Jost B Jonas; Ulrich H M Spandau; Frank Schlichtenbrede; Teodosio Libondi; Urs Vossmerbaeumer; Stefan von Baltz
Intravitreal bevacizumab combined with cataract surgery for treatment of exudative macular degeneration.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 2007;23(6):599-600.
2007: Jost B Jonas; Teodosio Libondi; Anna K Ihloff; Bjoern Harder; Ingrid Kreissig; Frank Schlichtenbrede; Gangolf Sauder; Ulrich H M Spandau
Visual acuity change after intravitreal bevacizumab for exudative age-related macular degeneration in relation to subfoveal membrane type.
Acta ophthalmologica Scandinavica 2007;85(5):563-5.
2007: Jost B Jonas; Ulrich H M Spandau; Florian Rensch; Stefan Von Baltz; Frank Schlichtenbrede
Infectious and noninfectious endophthalmitis after intravitreal bevacizumab.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 2007;23(3):240-2.
2007: Ulrich H M Spandau; Jost B Jonas
Intravitreal bevacizumab for peripapillary classic subretinal neovascularization.
Acta ophthalmologica Scandinavica 2007;85(3):340-1.
2007: Jost B Jonas; Ulrich H M Spandau; Bjoern Harder; Gangolf Sauder
Intravitreal triamcinolone acetonide for treatment of acute nonarteritic anterior ischemic optic neuropathy.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie 2007;245(5):749-50.
2007: Jost B Jonas; Ulrich H M Spandau; Bernd A Kamppeter; Bjoern Harder
Follow-up after intravitreal triamcinolone acetonide for exudative age-related macular degeneration.
Eye (London, England) 2007;21(3):387-94.
2007: Ulrich H M Spandau; Anne Wickenhäuser; Florian Rensch; Jost Jonas
Intravitreal bevacizumab for branch retinal vein occlusion.
Acta ophthalmologica Scandinavica 2007;85(1):118-9.
2007: Jost B Jonas; Ulrich H M Spandau; Frank Schlichtenbrede
Intravitreal bevacizumab for filtering surgery.
Ophthalmic research 2007;39(2):121-2.
2006: Ulrich H M Spandau; Jost B Jonas
Retinal pigment epithelium tear after intravitreal bevacizumab for exudative age-related macular degeneration.
American journal of ophthalmology 2006;142(6):1068-70.
2006: Jost B Jonas; Vanessa Strueven; Bernd A Kamppeter; Bjoern Harder; Ulrich H M Spandau; Frank Schlichtenbrede
Visual acuity change after intravitreal triamcinolone in various types of exudative age-related macular degeneration.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 2006;22(5):370-6.
2006: Jost B Jonas; Bjoern Harder; Ulrich H M Spandau; Bernd A Kamppeter; Teodosio Libondi; Gangolf Sauder
Bevacizumab for occult subfoveal neovascularization in age-related macular degeneration.
European journal of ophthalmology 2006;16(5):774-5.
2006: Jost B Jonas; Gangolf Sauder; Wido M Budde; Ulrich H M Spandau; Bernd A Kamppeter; Bjoern Harder
Triamcinolone acetonide-induced ocular hypertension.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 2006;22(4):247-50.
2006: Ulrich H M Spandau; Anna K Ihloff; Jost B Jonas
Intravitreal bevacizumab treatment of macular oedema due to central retinal vein occlusion.
Acta ophthalmologica Scandinavica 2006;84(4):555-6.
2006: Jost B Jonas; Ulrich H M Spandau; Bernd A Kamppeter; U Vossmerbaeumer; Bjoern Harder
Follow-up after intravitreal triamcinolone acetonide for diabetic macular edema.
European journal of ophthalmology 2006;16(4):566-72.
2006: Jost B Jonas; Bernd A Kamppeter; Bjoern Harder; Urs Vossmerbaeumer; Gangolf Sauder; Ulrich H M Spandau
Intravitreal triamcinolone acetonide for diabetic macular edema: a prospective, randomized study.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 2006;22(3):200-7.
2006: Jost B Jonas; Ulrich H M Spandau; Bernd A Kamppeter; Robert F Degenring; Ingrid Kreissig; Imren Akkoyun; Urs Vossmerbaeumer
Duration of the effect of intravitreal triamcinolone acetonide in eyes with exudative age-related macular degeneration.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 2006;22(3):194-9.
2006: Jost B Jonas; Ulrich H M Spandau
Repeated intravitreal triamcinolone acetonide for chronic sympathetic ophthalmia.
Acta ophthalmologica Scandinavica 2006;84(3):436.
2006: Jost B Jonas; Ulrich H M Spandau; Bernd A Kamppeter; Urs Vossmerbaeumer; Bjoern Harder; Gangolf Sauder
Repeated intravitreal high-dosage injections of triamcinolone acetonide for diffuse diabetic macular edema.
Ophthalmology 2006;113(5):800-4.
2006: Jost B Jonas; Ingrid Kreissig; Ulrich H M Spandau; Bjoern Harder
Infectious and noninfectious endophthalmitis after intravitreal high-dosage triamcinolone acetonide.
American journal of ophthalmology 2006;141(3):579-80.
2006: Christian Albrecht May; Andreas Ohlmann; Hans-Peter Hammes; Ulrich H M Spandau
Proteins with an endostatin-like domain in a mouse model of oxygen-induced retinopathy.
Experimental eye research 2006;82(2):341-8.
2006: Ulrich H M Spandau; Gangolf Sauder; J B Jonas
[Vision loss after contusio bulbi].
Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 2006;103(2):147-8.
2006: Jost B Jonas; Ulrich H M Spandau; Bernd A Kamppeter; Urs Vossmerbaeumer; Bjoern Harder
Repeated intravitreal injection of triamcinolone for exudative age-related macular degeneration.
Ophthalmic research 2006;38(6):324-8.
2006: Jost B Jonas; W Back; Gangolf Sauder; U Jünemann; Bjoern Harder; Ulrich H M Spandau
Sympathetic ophthalmia in vater association combined with persisting hyperplastic primary vitreous after cyclodestructive procedure.
European journal of ophthalmology 2006;16(1):171-2.
2005: Ulrich H M Spandau; M Derse; P Schmitz-Valckenberg; C Papoulis; J B Jonas
Dosage dependency of intravitreal triamcinolone acetonide as treatment for diabetic macular oedema.
The British journal of ophthalmology 2005;89(8):999-1003.
2005: Jost B Jonas; Ulrich H M Spandau; Bjoern Harder; Urs Vossmerbaeumer; Bernd A Kamppeter
Intereye difference in exudative age-related macular degeneration with minimally classic or occult subfoveal neovascularization after unilateral intravitreal injection of triamcinolone acetonide.
American journal of ophthalmology 2005;139(6):1073-9.
2005: Ulrich H M Spandau; Gangolf Sauder; Uwe Schubert; Hans-Peter Hammes; J B Jonas
Effect of triamcinolone acetonide on proliferation of retinal endothelial cells in vitro and in vivo.
The British journal of ophthalmology 2005;89(6):745-7.
2005: Ulrich H M Spandau; Mathias Derse; Paul Schmitz-Valckenberg; Christos Papoulis; Bernd-Udo Sagstetter; Karlheinz Stiefvater; Jost B Jonas
Triamcinolone acetonide concentration after filtration of the solvent agent.
American journal of ophthalmology 2005;139(4):712-3.
2004: Ulrich H M Spandau; Stefan Dithmar; Hans E Grossniklaus; Hans-Eberhard Völcker; Jost B Jonas
Recurrent spontaneous hyphaema secondary to a melanocytic iris lesion.
Acta ophthalmologica Scandinavica 2004;82(4):494-5.
2003: Ulrich H M Spandau; Atiye Toksoy; Soraya Verhaart; Reinhard Gillitzer; Friedrich E Kruse
High expression of chemokines Gro-alpha (CXCL-1), IL-8 (CXCL-8), and MCP-1 (CCL-2) in inflamed human corneas in vivo.
Archives of ophthalmology 2003;121(6):825-31.
2002: Ulrich H M Spandau; Jost B Jonas; Achim Gass
Progressive visual loss in optic nerve hypoplasia and bilateral microdiscs.
Archives of neurology 2002;59(11):1829-30.
2002: Ulrich H M Spandau; Eva-B Bröcker; Eckhart Kämpgen; Reinhard Gillitzer
CC and CXC chemokines are differentially expressed in erythema multiforme in vivo.
Archives of dermatology 2002;138(8):1027-33.
2002: Lisa M Astuto; Julie M Bork; Michael D Weston; James W Askew; R R Fields; Dana J Orten; S J Ohliger; Sheikh Amer Riazuddin; Robert J Morell; Shaheen Khan; S Riazuddin; Hannie Kremer; Peter Van Hauwe; CG Moller; Cor W R J Cremers; C Ayuso; John R Heckenlively; Klaus Rohrschneider; Ulrich H M Spandau; J Greenberg; Rajkumar Ramesar; William Reardon; P Bitoun; J Millan; R Legge; Thomas B Friedman; William J Kimberling
CDH23 mutation and phenotype heterogeneity: a profile of 107 diverse families with Usher syndrome and nonsyndromic deafness.
American journal of human genetics 2002;71(2):262-75.
2002: Ulrich H M Spandau; Klaus Rohrschneider
Prevalence and geographical distribution of Usher syndrome in Germany.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie 2002;240(6):495-8.
2002: Ulrich H M Spandau; Stefanie Wechsler; Anita Blankenagel
Testing night vision goggles in a dark outside environment.
Optometry and vision science : official publication of the American Academy of Optometry 2002;79(1):39-45.
2001: Christian R Otterstedde; Ulrich H M Spandau; Anita Blankenagel; William J Kimberling; Christoph Reisser
A new clinical classification for Usher's syndrome based on a new subtype of Usher's syndrome type I.
The Laryngoscope 2001;111(1):84-6.
2000: Klaus Rohrschneider; Ulrich H M Spandau; S Wechsler; Anita Blankenagel
[Utilization of a new night vision enhancement device (DAVIS)].
Klinische Monatsblätter für Augenheilkunde 2000;217(2):88-93.
1998: Ulrich H M Spandau; Atiye Toksoy; Matthias Goebeler; Eva-B Bröcker; Reinhard Gillitzer
MIG is a dominant lymphocyte-attractant chemokine in lichen planus lesions.
The Journal of investigative dermatology 1998;111(6):1003-9.
1998: Matthias Goebeler; Atiye Toksoy; Ulrich H M Spandau; E Engelhardt; Eva-B Bröcker; Reinhard Gillitzer
The C-X-C chemokine Mig is highly expressed in the papillae of psoriatic lesions.
The Journal of pathology 1998;184(1):89-95.
1996: Reinhard Gillitzer; Uwe Ritter; Ulrich H M Spandau; Matthias Goebeler; Eva-B Bröcker
Differential expression of GRO-alpha and IL-8 mRNA in psoriasis: a model for neutrophil migration and accumulation in vivo.
The Journal of investigative dermatology 1996;107(5):778-82.